Achievements and challenges in the use of metronomics for the treatment of breast cancer

Two interesting therapeutic proposals for cancer treatment emerged at the beginning of the 21st century. The first one was metronomic chemotherapy, which refers to the chronic administration of chemotherapeutic agents, in low doses, without extended drug-free periods. Then, the idea of drug repositi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Scharovsky, O. Graciela, Rico, María José, Mainetti, Leandro Ernesto, Perroud, Herman A, Rozados, Viviana R.
Formato: article artículo publishedVersion
Lenguaje:Español
Publicado: Elsevier 2020
Materias:
Acceso en línea:http://hdl.handle.net/2133/19359
http://hdl.handle.net/2133/19359
Aporte de:
id I15-R121-2133-19359
record_format dspace
institution Universidad Nacional de Rosario
institution_str I-15
repository_str R-121
collection Repositorio Hipermedial de la Universidad Nacional de Rosario (UNR)
language Español
orig_language_str_mv spa
topic Metronomic chemotherapy
Drug repositioning
Breast cancer
Triple negative
Preclinical-clinical
spellingShingle Metronomic chemotherapy
Drug repositioning
Breast cancer
Triple negative
Preclinical-clinical
Scharovsky, O. Graciela
Rico, María José
Mainetti, Leandro Ernesto
Perroud, Herman A
Rozados, Viviana R.
Achievements and challenges in the use of metronomics for the treatment of breast cancer
topic_facet Metronomic chemotherapy
Drug repositioning
Breast cancer
Triple negative
Preclinical-clinical
description Two interesting therapeutic proposals for cancer treatment emerged at the beginning of the 21st century. The first one was metronomic chemotherapy, which refers to the chronic administration of chemotherapeutic agents, in low doses, without extended drug-free periods. Then, the idea of drug repositioning in oncology, the use of well-known drugs that were created for other uses to be utilized in oncology, gained strength. Shortly after, the two strategies were merged in one, named metronomics. Both approaches share several features which make metronomics an appealing choice for cancer treatment: use of known and approved drugs, thus diminishing the time necessary to enter to the clinic, therapeutic effect, low toxicity, oral administration, better life quality, low costs because of the use of, generally, out of patent drugs, possibility of use, even in countries with very low economic resources. Many chemotherapy and repurposed drugs were tested with metronomics approaches for the treatment of mammary cancer, the most common malignancy in women worldwide, leading to high rates of mortality. The wide range of therapeutic models studied, paralleled the wide range of responses obtained, like tumor growth and metastasis inhibition, overall survival increase, lack of toxicity, better life quality, among others. The accomplishments reached, and the challenges faced by researchers, are discussed.
format article
artículo
publishedVersion
author Scharovsky, O. Graciela
Rico, María José
Mainetti, Leandro Ernesto
Perroud, Herman A
Rozados, Viviana R.
author_facet Scharovsky, O. Graciela
Rico, María José
Mainetti, Leandro Ernesto
Perroud, Herman A
Rozados, Viviana R.
author_sort Scharovsky, O. Graciela
title Achievements and challenges in the use of metronomics for the treatment of breast cancer
title_short Achievements and challenges in the use of metronomics for the treatment of breast cancer
title_full Achievements and challenges in the use of metronomics for the treatment of breast cancer
title_fullStr Achievements and challenges in the use of metronomics for the treatment of breast cancer
title_full_unstemmed Achievements and challenges in the use of metronomics for the treatment of breast cancer
title_sort achievements and challenges in the use of metronomics for the treatment of breast cancer
publisher Elsevier
publishDate 2020
url http://hdl.handle.net/2133/19359
http://hdl.handle.net/2133/19359
work_keys_str_mv AT scharovskyograciela achievementsandchallengesintheuseofmetronomicsforthetreatmentofbreastcancer
AT ricomariajose achievementsandchallengesintheuseofmetronomicsforthetreatmentofbreastcancer
AT mainettileandroernesto achievementsandchallengesintheuseofmetronomicsforthetreatmentofbreastcancer
AT perroudhermana achievementsandchallengesintheuseofmetronomicsforthetreatmentofbreastcancer
AT rozadosvivianar achievementsandchallengesintheuseofmetronomicsforthetreatmentofbreastcancer
bdutipo_str Repositorios
_version_ 1764820410710360065